
Chromosome 5q- syndrome: A blood disorder due to the loss of part of the long (q) arm of chromosome 5 in myeloid (bone marrow) cells, causing refractory (treatment-resistant) <a href="https://www.medicinenet.com/anemia/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">anemia</a>, and myelodysplastic syndrome that is generally associated with a good prognosis but on occasion may lead to acute myeloid <a href="https://www.medicinenet.com/leukemia/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">leukemia</a> (AML).  The immune modulating lenalidomide (Revlimid) is beneficial in male patients with the 5Q- syndrome and may reduce transfusion needs. It does lower white blood cells and platelet counts and is not a curative option.